Unmet Needs in Narcolepsy and Clinical Pearls
Neurology experts discuss the unmet needs in narcolepsy treatment and share clinical pearls from their experiences.
Sodium Oxybate and Antidepressants for Treatment of Cataplexy
Experts discuss sodium oxybate and antidepressants for treatment of cataplexy.
Solriamfetol Efficacy and Safety
Experts discuss the efficacy and safety profile of solriamfetol for the treatment of narcolepsy.
Pitolisant Efficacy and Safety
Anne Marie Morse, DO, FAASM, discusses the efficacy and safety profile of pitolisant for the treatment of narcolepsy.
Pitolisant: Mechanism of Action
Thomas E. Scammell, MD, provides an overview of the mechanism of action of pitolisant for the treatment of narcolepsy.
EDS and Narcolepsy Treatment Options
Neurology experts discuss excessive daytime sleepiness (EDS) and narcolepsy treatment options.
Pharmacological Treatment Options for Narcolepsy
Karl Doghramji, MD, FAASM, DFAPA, provides an overview of the pharmacological treatment options for narcolepsy.
Goals of Therapy for Narcolepsy
Neurology experts describe the goals of therapy for narcolepsy treatment.
Available Resources for Narcolepsy Treatment
Debra Stultz, MD, provides an overview of the available resources that are available for narcolepsy treatment.
Thomas E. Scammell, MD, discusses evaluating excessive daytime sleepiness (EDS).
Diagnosis of Narcolepsy
Experts discuss narcolepsy diagnosis and the challenges associated with it.
Burden and Risk Factor of Narcolepsy
Anne Marie Morse, DO, FAASM, discusses the burden and risk factors associated with excessive daytime sleepiness and narcolepsy.
Experts provide an overview of excessive daytime sleepiness and narcolepsy.
The Potential of MCHR1 Antagonists in Narcolepsy: Thomas Scammell, MD
The professor of neurology at Beth Israel Deaconess Medical Center discussed the treatment potential of melanin concentrating hormone receptor 1 antagonists for narcolepsy. [WATCH TIME: 3 minutes]
2 Commerce Drive Cranbury, NJ 08512